Dipeptidyl Peptidase Iv Inhibition Improves Chamber Compliance and Reduces Lv Hypertrophy in a Rodent Model of Myocardial Infarction With Diabetes

被引：0
|
作者：
Connelly, Kim A. Esq
Golam, Kabir
Desjardins, Jean Francois
Thai, Kerri
Advani, Suzanne L.
Zhang, Yanling
Yuen, Darren
Advani, Andrew
Gilbert, Richard E.
机构：
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Rsch Cntr, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
CIRCULATION | 2011年 / 124卷 / 21期
关键词：
Type; 1; Diabetes; Myocardial infarction; Glucose; Hypertrophy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13024
引用
收藏
页数：2
相关论文
共 16 条
  • [1] Inhibition of Dipeptidyl Peptidase IV Improves Left Ventricular Compliance in Obese Diabetic Mice
    Hervent, Anne-Sophie
    Hamdani, Nazha
    Matheeussen, Veerle
    Demolder, Marc
    De Meester, Ingrid
    Paulus, Walter
    De Keulenaer, Gilles
    CIRCULATION, 2012, 126 (21)
  • [2] Inhibition of dipeptidyl peptidase IV improves left ventricular compliance in obese diabetic mice.
    Hervent, A-S.
    Hamdani, N.
    De Meester, I.
    Linke, W.
    Paulus, W.
    De Keulenaer, G. W. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S351 - S351
  • [3] Effects of dipeptidyl peptidase IV inhibition on left ventricular compliance in obese mice with type II diabetes
    Hervent, A. -S.
    Hamdani, N.
    Matheeussen, V.
    Demolder, M.
    De Meester, I.
    Linke, W. A.
    Paulus, W. J.
    De Keulenaer, G. W.
    EUROPEAN HEART JOURNAL, 2013, 34 : 451 - 451
  • [4] The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
    Gallagher, Emily Jane
    Sun, Hui
    Kornhauser, Caroline
    Tobin-Hess, Aviva
    Epstein, Sol
    Yakar, Shoshana
    LeRoith, Derek
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (03) : 191 - 200
  • [5] Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
    Sauve, Meghan
    Ban, Kiwon
    Momen, M. Abdul
    Zhou, Yu-Qing
    Henkelman, R. Mark
    Husain, Mansoor
    Drucker, Daniel J.
    DIABETES, 2010, 59 (04) : 1063 - 1073
  • [6] Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes
    Ahrén, B
    Simonsson, E
    Larsson, H
    Landin-Olsson, M
    Torgeirsson, H
    Jansson, PA
    Sandqvist, M
    Båvenholm, P
    Efendic, S
    Eriksson, JW
    Dickinson, S
    Holmes, D
    DIABETES CARE, 2002, 25 (05) : 869 - 875
  • [7] Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity
    Bostick, Brian
    Habibi, Javad
    Ma, Lixin
    Aroor, Annayya
    Rehmer, Nathan
    Hayden, Melvin R.
    Sowers, James R.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (08): : 1000 - 1011
  • [8] Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes
    Mari, A
    Sallas, WM
    He, YL
    Watson, C
    Ligueros-Saylan, M
    Dunning, BE
    Deacon, CF
    Holst, JJ
    Foley, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08): : 4888 - 4894
  • [9] Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes
    Mu, James
    Woods, John
    Zhou, Yun-Ping
    Roy, Ranabir Sinha
    Li, Zhihua
    Zycband, Emanuel
    Feng, Yue
    Zhu, Lan
    Li, Cai
    Howard, Andrew D.
    Moller, David. E.
    Thornberry, Nancy A.
    Zhang, Bei B.
    DIABETES, 2006, 55 (06) : 1695 - 1704
  • [10] Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α
    Connelly, Kim A.
    Advani, Andrew
    Zhang, Yanling
    Advani, Suzanne L.
    Kabir, Golam
    Abadeh, Armin
    Desjardins, Jean-Francois
    Mitchell, Melissa
    Thai, Kerri
    Gilbert, Richard E.
    JOURNAL OF DIABETES, 2016, 8 (01) : 63 - 75
12